{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:17Z","timestamp":1787020757417,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009836","name":"Huntington Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000034","name":"Institute of Neurosciences, Mental Health and Addiction","doi-asserted-by":"publisher","award":["119437"],"award-info":[{"award-number":["119437"]}],"id":[{"id":"10.13039\/501100000034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13041-019-0456-1","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T10:03:47Z","timestamp":1554717827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington\u2019s pathology in zQ175 mice"],"prefix":"10.1186","volume":"12","author":[{"given":"Khaled S.","family":"Abd-Elrahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0887-7312","authenticated-orcid":false,"given":"Stephen S. G.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"456_CR1","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","volume":"330","author":"B Kremer","year":"1994","unstructured":"Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J, et al. A worldwide study of the Huntington\u2019s disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med. 1994;330:1401\u20136 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8159192\n                    \n                  . [cited 2016 Oct 20].","journal-title":"N Engl J Med"},{"key":"456_CR2","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997;277:1990\u20133 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9302293\n                    \n                  . [cited 2016 Oct 27].","journal-title":"Science"},{"key":"456_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","volume":"20","author":"S-H Li","year":"2004","unstructured":"Li S-H, Li X-J. Huntingtin-protein interactions and the pathogenesis of Huntington\u2019s disease. Trends Genet. 2004;20:146\u201354 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15036808\n                    \n                  . [cited 2016 Oct 20].","journal-title":"Trends Genet"},{"key":"456_CR4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E. Molecular Mechanisms and Potential Therapeutical Targets in Huntington\u2019s Disease. Physiol Rev. 2010;90:905\u201381 Available from: \n                    http:\/\/physrev.physiology.org\/cgi\/doi\/10.1152\/physrev.00041.2009\n                    \n                  . [cited 2016 Nov 1].","journal-title":"Physiol Rev"},{"key":"456_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1212\/WNL.38.3.341","volume":"38","author":"RH Myers","year":"1988","unstructured":"Myers RH, Vonsattel JP, Stevens TJ, Cupples LA, Richardson EP, Martin JB, et al. Clinical and neuropathologic assessment of severity in Huntington\u2019s disease. Neurology. 1988;38:341\u20137 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2964565\n                    \n                  . [cited 2016 Oct 20].","journal-title":"Neurology"},{"key":"456_CR6","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10:S10\u20137 Available from: \n                    http:\/\/www.nature.com\/doifinder\/10.1038\/nm1066\n                    \n                  . [cited 2016 Nov 1].","journal-title":"Nat Med"},{"key":"456_CR7","doi-asserted-by":"publisher","first-page":"574","DOI":"10.2174\/187152710793361612","volume":"9","author":"FM Ribeiro","year":"2010","unstructured":"Ribeiro FM, Paquet M, Cregan SP, Ferguson SSG. Group I metabotropic glutamate receptor signalling and its implication in neurological disease. CNS Neurol Disord Drug Targets. 2010;9:574\u201395 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20632969\n                    \n                  . [cited 2017 Dec 13].","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"456_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0304-3940(93)90227-C","volume":"163","author":"R Shigemoto","year":"1993","unstructured":"Shigemoto R, Nomura S, Ohishi H, Sugihara H, Nakanishi S, Mizuno N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci Lett. 1993;163:53\u20137 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8295733\n                    \n                  . [cited 2016 Oct 20].","journal-title":"Neurosci Lett"},{"key":"456_CR9","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1093\/hmg\/ddt598","volume":"23","author":"FM Ribeiro","year":"2014","unstructured":"Ribeiro FM, Devries RA, Hamilton A, Guimaraes IM, Cregan SP, Pires RGW, et al. Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington\u2019s disease. Hum Mol Genet. 2014;23:2030\u201342 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24282028\n                    \n                  . [cited 2016 Oct 19].","journal-title":"Hum Mol Genet"},{"key":"456_CR10","doi-asserted-by":"publisher","first-page":"eaan6387","DOI":"10.1126\/scisignal.aan6387","volume":"10","author":"KS Abd-Elrahman","year":"2017","unstructured":"Abd-Elrahman KS, Hamilton A, Hutchinson SR, Liu F, Russell RC, SSG F. mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington\u2019s disease. Sci Signal. 2017;10:eaan6387 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29259100\n                    \n                  . [cited 2019 Feb 27].","journal-title":"Sci Signal"},{"key":"456_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1124\/jpet.111.185660","volume":"339","author":"L Lindemann","year":"2011","unstructured":"Lindemann L, Jaeschke G, Michalon A, Vieira E, Honer M, Spooren W, et al. CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor. J Pharmacol Exp Ther. 2011;339:474\u201386 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21849627\n                    \n                  . [cited 2016 Oct 21].","journal-title":"J Pharmacol Exp Ther"},{"key":"456_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jamapsychiatry.2016.0838","volume":"73","author":"JA Quiroz","year":"2016","unstructured":"Quiroz JA, Tamburri P, Deptula D, Banken L, Beyer U, Rabbia M, et al. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression. JAMA Psychiatry. 2016;73:675 Available from: \n                    http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2016.0838\n                    \n                  . [cited 2016 Nov 15].","journal-title":"JAMA Psychiatry"},{"key":"456_CR13","doi-asserted-by":"publisher","unstructured":"Abd-Elrahman KS, Hamilton A, Vasefi M, Ferguson SSG. Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer\u2019s disease mouse models. Mol Brain. 2018;11(1):19. \n                    https:\/\/doi.org\/10.1186\/s13041-018-0364-9\n                    \n                  .","DOI":"10.1186\/s13041-018-0364-9"},{"key":"456_CR14","doi-asserted-by":"publisher","first-page":"12297","DOI":"10.1074\/jbc.M900573200","volume":"284","author":"IG Ganley","year":"2009","unstructured":"Ganley IG, Lam DH, Wang J, Ding X, Chen S, Jiang X. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J. Biol. Chem. 2009;284:12297\u2013305 American Society for Biochemistry and Moleculsar Biology. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19258318\n                    \n                  . [cited 2017 Aug 3].","journal-title":"J. Biol. Chem"},{"key":"456_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1042\/EBC20170021","volume":"61","author":"M Zachari","year":"2017","unstructured":"Zachari M, Ganley IG. The mammalian ULK1 complex and autophagy initiation. Essays Biochem. 2017;61:585\u201396 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29233870\n                    \n                  . [cited 2019 Feb 21].","journal-title":"Essays Biochem"},{"key":"456_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0166-2236(00)01609-X","volume":"23","author":"C J-HJ","year":"2000","unstructured":"J-HJ C. Transcriptional dysregulation in Huntington\u2019s disease. Trends Neurosci. 2000;23:387\u201392 Elsevier Current Trends. Available from: \n                    https:\/\/www.sciencedirect.com\/science\/article\/pii\/S016622360001609X\n                    \n                  . [cited 2019 Feb 21].","journal-title":"Trends Neurosci"},{"key":"456_CR17","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"D Rigamonti","year":"2000","unstructured":"Rigamonti D, Bauer JH, De-Fraja C, Conti L, Sipione S, Sciorati C, et al. Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci. 2000;20:3705\u201313 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10804212\n                    \n                  . [cited 2019 Feb 21].","journal-title":"J Neurosci"},{"key":"456_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1523\/JNEUROSCI.19-03-00964.1999","volume":"19","author":"M Kim","year":"1999","unstructured":"Kim M, Lee HS, LaForet G, McIntyre C, Martin EJ, Chang P, et al. Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci. 1999;19:964\u201373 Society for Neuroscience. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9920660\n                    \n                  . [cited 2019 Feb 21].","journal-title":"J Neurosci"},{"key":"456_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan K-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132\u201341 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21258367\n                    \n                  . [cited 2017 Aug 3].","journal-title":"Nat Cell Biol"},{"key":"456_CR20","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","volume":"584","author":"CH Jung","year":"2010","unstructured":"Jung CH, Ro S-H, Cao J, Otto NM, Kim D-H. mTOR regulation of autophagy. FEBS Lett. 2010;584:1287\u201395 NIH Public Access. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20083114\n                    \n                  . [cited 2017 Aug 3].","journal-title":"FEBS Lett"},{"key":"456_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","volume":"84","author":"M Perluigi","year":"2015","unstructured":"Perluigi M, Di Domenico F, Butterfield DA. mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy. Neurobiol Dis. 2015;84:39\u201349 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25796566\n                    \n                  . [cited 2019 Feb 22].","journal-title":"Neurobiol Dis"},{"key":"456_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/1535-7163.MCT-10-0654","volume":"10","author":"S Banerjee","year":"2011","unstructured":"Banerjee S, Gianino SM, Gao F, Christians U, Gutmann DH. Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes. Mol Cancer Ther. 2011;10:279\u201391 Available from: \n                    http:\/\/mct.aacrjournals.org\/cgi\/doi\/10.1158\/1535-7163.MCT-10-0654\n                    \n                  . [cited 2017 Jan 11].","journal-title":"Mol Cancer Ther"},{"key":"456_CR23","doi-asserted-by":"publisher","first-page":"25464","DOI":"10.1074\/jbc.M703663200","volume":"282","author":"C EYW","year":"2007","unstructured":"EYW C, Kir S, Tooze SA. siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy. J Biol Chem. 2007;282:25464\u201374 Available from: \n                    http:\/\/www.jbc.org\/lookup\/doi\/10.1074\/jbc.M703663200\n                    \n                  . [cited 2017 Aug 3].","journal-title":"J Biol Chem"},{"key":"456_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0076-6879(08)03611-2","volume":"452","author":"T Ikenoue","year":"2009","unstructured":"Ikenoue T, Hong S, Inoki K. Chapter 11 Monitoring Mammalian Target of Rapamycin (mTOR) Activity. Methods Enzymol. 2009;452:165\u201380 Academic Press. Available from: \n                    https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0076687908036112?via%3Dihub\n                    \n                  . [cited 2019 Feb 22].","journal-title":"Methods Enzymol"},{"key":"456_CR25","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1523\/JNEUROSCI.22-20-08838.2002","volume":"22","author":"W-M Zho","year":"2002","unstructured":"Zho W-M, You J-L, Huang C-C, Hsu K-S. The group I metabotropic glutamate receptor agonist (S)-3,5-dihydroxyphenylglycine induces a novel form of depotentiation in the CA1 region of the hippocampus. J Neurosci. 2002;22:8838\u201349 Society for Neuroscience. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12388590\n                    \n                  . [cited 2019 Feb 22].","journal-title":"J Neurosci"},{"key":"456_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fonc.2014.00064","volume":"4","author":"C Porta","year":"2014","unstructured":"Porta C, Paglino C, Mosca A. Targeting PI3K\/Akt\/mTOR Signaling in Cancer. Front Oncol. 2014;4:64 Frontiers. Available from: \n                    http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2014.00064\/abstract\n                    \n                  . [cited 2019 Feb 22].","journal-title":"Front Oncol"},{"key":"456_CR27","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/j.1471-4159.2005.03474.x","volume":"95","author":"F Liu","year":"2005","unstructured":"Liu F, Gong X, Zhang G, Marquis K, Reinhart P, Andree TH. The inhibition of glycogen synthase kinase 3\u03b2 by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to A\u03b2 peptides. J Neurochem. 2005;95:1363\u201372 Blackwell Science Ltd. Available from: \n                    http:\/\/doi.wiley.com\/10.1111\/j.1471-4159.2005.03474.x\n                    \n                  . [cited 2018 Jan 10].","journal-title":"J Neurochem"},{"key":"456_CR28","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1523\/JNEUROSCI.0995-04.2004","volume":"24","author":"L Hou","year":"2004","unstructured":"Hou L, Klann E. Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci. 2004;24:6352\u201361 Available from: \n                    http:\/\/www.jneurosci.org\/cgi\/doi\/10.1523\/JNEUROSCI.0995-04.2004\n                    \n                  . [cited 2019 Feb 22].","journal-title":"J Neurosci"},{"key":"456_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fncel.2017.00184","volume":"11","author":"D Gandolfi","year":"2017","unstructured":"Gandolfi D, Cerri S, Mapelli J, Polimeni M, Tritto S, Fuzzati-Armentero M-T, et al. Activation of the CREB\/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer. Front Cell Neurosci. 2017;11:184 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28701927\n                    \n                  . [cited 2019 Feb 21].","journal-title":"Front Cell Neurosci"},{"key":"456_CR30","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tins.2017.10.002","volume":"40","author":"CA Saura","year":"2017","unstructured":"Saura CA, Cardinaux J-R. Emerging Roles of CREB-Regulated Transcription Coactivators in Brain Physiology and Pathology. Trends Neurosci. 2017;40:720\u201333 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29097017\n                    \n                  . [cited 2019 Feb 23].","journal-title":"Trends Neurosci"},{"key":"456_CR31","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0896-6273(00)80395-5","volume":"19","author":"S Finkbeiner","year":"1997","unstructured":"Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME. CREB: A Major Mediator of Neuronal Neurotrophin Responses. Neuron. 1997;19:1031\u201347 Cell Press. Available from: \n                    https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0896627300803955\n                    \n                  . [cited 2019 Feb 22].","journal-title":"Neuron"},{"key":"456_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng882","volume":"31","author":"T Mantamadiotis","year":"2002","unstructured":"Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, Villalba AM, et al. Disruption of CREB function in brain leads to neurodegeneration. Nat Genet. 2002;31:47\u201354 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11967539\n                    \n                  . [cited 2019 Feb 23].","journal-title":"Nat Genet"},{"key":"456_CR33","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr","year":"2001","unstructured":"Nucifora FC Jr, Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, et al. Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity. Science. 2001;291:2423\u20138 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11264541\n                    \n                  . [cited 2019 Feb 23].","journal-title":"Science"},{"issue":"12","key":"456_CR34","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"J. S. Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, et al. The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci USA. 2000;97:6763\u20138. Available from: \n                    http:\/\/www.pnas.org\/cgi\/doi\/10.1073\/pnas.100110097\n                    \n                  . [cited 2019 Apr 2].","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"456_CR35","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/mds.26020","volume":"29","author":"N Aronin","year":"2014","unstructured":"Aronin N, DiFiglia M. Huntingtin-lowering strategies in Huntington\u2019s disease: Antisense oligonucleotides, small RNAs, and gene editing. Mov Disord. 2014;29:1455\u201361 Available from: \n                    http:\/\/doi.wiley.com\/10.1002\/mds.26020\n                    \n                  . [cited 2019 Mar 4].","journal-title":"Mov Disord"},{"key":"456_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1517\/14712598.2016.1114096","volume":"16","author":"C-J Choong","year":"2016","unstructured":"Choong C-J, Baba K, Mochizuki H. Gene therapy for neurological disorders. Expert Opin Biol Ther. 2016;16:143\u201359 Available from: \n                    http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14712598.2016.1114096\n                    \n                  . [cited 2019 Mar 4].","journal-title":"Expert Opin Biol Ther"},{"key":"456_CR37","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/ijms20030728","volume":"20","author":"Z Zhu","year":"2019","unstructured":"Zhu Z, Yang C, Iyaswamy A, Krishnamoorthi S, Sreenivasmurthy SG, Liu J, et al. Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson\u2019s Disease. Int J Mol Sci. 2019;20:728 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30744070\n                    \n                  . [cited 2019 Feb 22].","journal-title":"Int J Mol Sci"},{"key":"456_CR38","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1080\/15548627.2015.1106668","volume":"11","author":"MJ Munson","year":"2015","unstructured":"Munson MJ, Ganley IG. MTOR, PIK3C3, and autophagy: Signaling the beginning from the end. Autophagy. 2015;11:2375\u20136 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26565689\n                    \n                  . [cited 2019 Feb 22].","journal-title":"Autophagy"},{"key":"456_CR39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1039\/b804606a","volume":"4","author":"S Sarkar","year":"2008","unstructured":"Sarkar S, Rubinsztein DC. Small molecule enhancers of autophagy for neurodegenerative diseases. Mol Biosyst. 2008;4:895\u2013901 Available from: \n                    http:\/\/xlink.rsc.org\/?DOI=b804606a\n                    \n                  . [cited 2017 Jan 11].","journal-title":"Mol Biosyst"},{"key":"456_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4161\/auto.1.1.1513","volume":"1","author":"DC Rubinsztein","year":"2005","unstructured":"Rubinsztein DC, DiFiglia M, Heintz N, Nixon RA, Qin Z-H, Ravikumar B, et al. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy. 2005;1:11\u201322 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16874045\n                    \n                  . [cited 2017 Nov 15].","journal-title":"Autophagy"},{"key":"456_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.14348\/molcells.2015.0034","volume":"38","author":"J Nah","year":"2015","unstructured":"Nah J, Yuan J, Jung Y-K. Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach. Mol Cells. 2015;38:381\u20139 Korean Society for Molecular and Cellular Biology. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25896254\n                    \n                  . [cited 2018 mar 7].","journal-title":"Mol Cells"},{"key":"456_CR42","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19:983\u201397 Nature Publishing Group. Available from: \n                    http:\/\/www.nature.com\/articles\/nm.3232\n                    \n                  . [cited 2018 Mar 7].","journal-title":"Nat Med"},{"issue":"7","key":"456_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ncb2757","volume":"15","author":"Ryan C. Russell","year":"2013","unstructured":"Russell RC, Tian Y, Yuan H, Park HW, Chang Y-Y, Kim J, et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol. Nature Publishing Group. 2013;15:741\u201350. Available from: \n                    http:\/\/www.nature.com\/articles\/ncb2757\n                    \n                  . [cited 2019 Apr 2].","journal-title":"Nature Cell Biology"},{"key":"456_CR44","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.1074\/jbc.M115.689646","volume":"291","author":"C Puente","year":"2016","unstructured":"Puente C, Hendrickson RC, Jiang X. Nutrient-regulated Phosphorylation of ATG13 Inhibits Starvation-induced Autophagy. J Biol Chem. 2016;291:6026\u201335 Available from: \n                    http:\/\/www.jbc.org\/lookup\/doi\/10.1074\/jbc.M115.689646\n                    \n                  . [cited 2019 Feb 22].","journal-title":"J Biol Chem"},{"key":"456_CR45","doi-asserted-by":"publisher","first-page":"34840","DOI":"10.1074\/jbc.M504508200","volume":"280","author":"PH Anborgh","year":"2005","unstructured":"Anborgh PH, Godin C, Pampillo M, Dhami GK, Dale LB, Cregan SP, et al. Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin. J Biol Chem. 2005;280:34840\u20138 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16091361\n                    \n                  . [cited 2016 Oct 20].","journal-title":"J Biol Chem"},{"key":"456_CR46","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s10571-010-9543-7","volume":"30","author":"S-S Huang","year":"2010","unstructured":"Huang S-S, He J, Zhao D-M, Xu X-Y, Tan H-P, Li H. Effects of Mutant Huntingtin on mGluR5-Mediated Dual Signaling Pathways: Implications for Therapeutic Interventions. Cell Mol Neurobiol. 2010;30:1107\u201315 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20644995\n                    \n                  . [cited 2019 mar 4].","journal-title":"Cell Mol Neurobiol"},{"key":"456_CR47","first-page":"189","volume":"3","author":"H Wang","year":"2012","unstructured":"Wang H, Zhuo M. Group I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases. Front Pharmacol. 2012;3:189 Frontiers Media SA. Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23125836\n                    \n                  . [cited 2019 Feb 26].","journal-title":"Front Pharmacol"},{"key":"456_CR48","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","volume":"20","author":"X Tao","year":"1998","unstructured":"Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME. Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism. Neuron. 1998;20:709\u201326 Cell Press. Available from: \n                    https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0896627300810107\n                    \n                  . [cited 2019 Feb 22].","journal-title":"Neuron"},{"key":"456_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-6606-5-14","volume":"5","author":"ER Kandel","year":"2012","unstructured":"Kandel ER. The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB. Mol Brain. 2012;5:14 Available from: \n                    http:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/1756-6606-5-14\n                    \n                  . [cited 2019 Feb 26].","journal-title":"Mol Brain"},{"key":"456_CR50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0896-6273(02)00655-4","volume":"34","author":"JM Kornhauser","year":"2002","unstructured":"Kornhauser JM, Cowan CW, Shaywitz AJ, Dolmetsch RE, Griffith EC, Hu LS, et al. CREB transcriptional activity in neurons is regulated by multiple, calcium-specific phosphorylation events. Neuron. 2002;34:221\u201333 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11970864\n                    \n                  . [cited 2019 Feb 26].","journal-title":"Neuron"},{"key":"456_CR51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neulet.2006.02.063","volume":"400","author":"M Dong","year":"2006","unstructured":"Dong M, Wu Y, Fan Y, Xu M, Zhang J. c-fos modulates brain-derived neurotrophic factor mRNA expression in mouse hippocampal CA3 and dentate gyrus neurons. Neurosci Lett. 2006;400:177\u201380 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16530956\n                    \n                  . [cited 2019 mar 27].","journal-title":"Neurosci Lett"},{"key":"456_CR52","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ejphar.2011.03.055","volume":"660","author":"M El-Sayed","year":"2011","unstructured":"El-Sayed M, Hofman-Bang J, Mikkelsen JD. Effect of brain-derived neurotrophic factor on activity-regulated cytoskeleton-associated protein gene expression in primary frontal cortical neurons. Comparison with NMDA and AMPA. Eur. J. Pharmacol. 2011;660:351\u20137 Available from: \n                    https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991100402X\n                    \n                  . [cited 2019 Mar 27].","journal-title":"Eur. J. Pharmacol"},{"key":"456_CR53","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1046\/j.1471-4159.1996.66062279.x","volume":"66","author":"C Gaiddon","year":"1996","unstructured":"Gaiddon C, Loeffler JP, Larmet Y. Brain-derived neurotrophic factor stimulates AP-1 and cyclic AMP-responsive element dependent transcriptional activity in central nervous system neurons. J Neurochem. 1996;66:2279\u201386 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8632149\n                    \n                  . [cited 2019 mar 27].","journal-title":"J Neurochem"},{"key":"456_CR54","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ng859","volume":"30","author":"J Zhang","year":"2002","unstructured":"Zhang J, Zhang D, McQuade JS, Behbehani M, Tsien JZ, Xu M. c-fos regulates neuronal excitability and survival. Nat Genet. 2002;30:416\u201320 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11925568\n                    \n                  . [cited 2019 Feb 22].","journal-title":"Nat Genet"},{"key":"456_CR55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1196\/annals.1403.009","volume":"1122","author":"RH LIPSKY","year":"2007","unstructured":"LIPSKY RH, MARINI AM. Brain-Derived Neurotrophic Factor in Neuronal Survival and Behavior-Related Plasticity. Ann N Y Acad Sci. 2007;1122:130\u201343 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18077569\n                    \n                  . [cited 2019 mar 27].","journal-title":"Ann N Y Acad Sci"},{"key":"456_CR56","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","volume":"21","author":"A Giralt","year":"2012","unstructured":"Giralt A, Puigdell\u00edvol M, Carret\u00f3n O, Paoletti P, Valero J, Parra-Damas A, et al. Long-term memory deficits in Huntington\u2019s disease are associated with reduced CBP histone acetylase activity. Hum Mol Genet. 2012;21:1203\u201316 Available from: \n                    https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddr552\n                    \n                  .[cited 2019 Feb 26].","journal-title":"Hum Mol Genet"},{"key":"456_CR57","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.celrep.2016.04.077","volume":"15","author":"A Hamilton","year":"2016","unstructured":"Hamilton A, Vasefi M, Vander Tuin C, McQuaid RJ, Anisman H, Ferguson SSG. Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model. Cell Rep. 2016;15:1859\u201365 Available from: \n                    http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27210751\n                    \n                  . [cited 2016 Oct 19].","journal-title":"Cell Rep"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-019-0456-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13041-019-0456-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-019-0456-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T19:19:34Z","timestamp":1586200774000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-019-0456-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1186\/s13041-019-0456-1","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"4 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were conducted in accordance with University of Ottawa animal care committees.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"35"}}